Phenoxodiol
Phenoxodiol (Idronoxil) is a broad-acting anticancer research compound that promotes apoptosis by targeting XIAP and FLIP, induces G1/S cell cycle arrest via p21 upregulation, and inhibits topoisomerase II. It has demonstrated pro-apoptotic and chemosensitizing effects in various cancer cell lines in vitro and has been investigated in preclinical in vivo models.
Product Specifications
CAS Number
81267-65-4
Product Name Alternative
Apoptosis, Caspase, DNA topoisomerase II, CP70, Dehydroequol, Idronoxil, Haginin E, inhibit, Inhibitor, p53, ovarian cancer, Phenoxodiol, Topoisomerase, topoisomerase II, prostate cancer, XIAP
Field of Research
Cell Biology, Molecular Biology, Protein Biochemistry
Purity
98.07% (May vary between batches)
Solubility
DMSO:50 mg/mL (208.12 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.32 mM)
Smiles
Oc1ccc (cc1) C1=Cc2ccc (O) cc2OC1
Molecular Formula
C15H12O3
Molecular Weight
240.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1182175-01 0.02 mg (E-Coli)
Recombinant Microcystis aeruginosa FO synthase subunit 2 (cofH)
Sign In for Pricing
View Details MBS1182175-02 0.02 mg (Yeast)
Recombinant Microcystis aeruginosa FO synthase subunit 2 (cofH)
Sign In for Pricing
View Details MBS1182175-03 0.1 mg (E-Coli)
Recombinant Microcystis aeruginosa FO synthase subunit 2 (cofH)
Sign In for Pricing
View Details